Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L Küssel is active.

Publication


Featured researches published by L Küssel.


Human Immunology | 2011

Prevalence and qualitative properties of circulating anti–human leukocyte antigen alloantibodies after pregnancy: No association with unexplained recurrent miscarriage

Gregor Bartel; Katharina Walch; Markus Wahrmann; Sophie Pils; L Küssel; Stephan Polterauer; Clemens Tempfer; Georg A. Böhmig

In pregnant women, circulating alloantibodies, triggered by exposure to paternal HLA antigens, are frequently detectable. The finding of lower alloantibody levels in women who experience spontaneous abortion (miscarriage) has led to the speculation that antipaternal antibodies could favor maintenance of pregnancy, whereas their lack poses a risk of miscarriage. Postulating a role of alloantibodies in the pathogenesis of unexplained abortion, we examined whether different categories of recurrent miscarriage (RM) can be distinguished according to prevalence or distinct qualitative properties of anti-human leukocyte antigen (HLA) antibody patterns. Sera obtained from 167 women with RM were assessed for complement- and non-complement-fixing anti-HLA alloreactivity using Luminex-based bead array technology. Women with RM had less often detectable anti-HLA class I and/or II reactivity (19%) compared with a control group of 96 multiparous women without a history of miscarriage (49%). However, analysis of different categories of RM (unknown [n = 112] versus known cause [n = 55]; primary [n = 125] versus secondary RM [n = 42]) did not reveal any differences regarding antibody prevalence, number of targeted HLA single antigens, antigen specificity, binding density, or complement-fixing ability of detected alloantibodies. Our results do not support a link between anti-HLA antibody formation and RM, and argue against a diagnostic value of alloantibody detection in the diagnostic work-up of women with RM.


Hypertension in Pregnancy | 2014

Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia

Julia Wild; Petra Pateisky; L Küssel; Wolfgang Huf; Johannes Ott; Peter Haslinger; Martin Knöfler; Harald Zeisler

Introduction: The role of preeclampsia (PE) in affecting bone metabolism could not be clarified in the past years. Recently Sclerostin, a new marker of bone metabolism which is known to have an inhibitory effect on bone formation causing osteoporosis, was discovered. Objective: To investigate serum levels of Sclerostin and markers of bone turnover in women with normotensive pregnancies and pregnancies complicated by PE. Methods: In this prospective study we enrolled 22 women with PE and 22 healthy pregnant women to observe serum levels of carboxyterminal propeptide of type I collagen (PICP), cross-linked carboxyl terminal telopeptide of the type I collagen (ICTP), calcium, phosphate, 25-hydroxyvitamin D and parathyroid hormone. In 16 preeclamptic and 16 healthy pregnant women, serum Sclerostin levels were analyzed. Results: Serum levels of Sclerostin (mean ± standard deviation: healthy 10.5 ± 8.1 pmol/l versus PE 11.5 ± 9.4 pmol/l, p = 0.768), ICTP (healthy 0.3 ± 0.2 ng/ml versus PE 0.4 ± 0.1 ng/ml, p = 0.462), PICP (healthy 59.9 ± 49.9 ng/ml versus PE 89.0 ± 62.0 ng/ml, p = 0.094), phosphate (healthy 1.1 ± 0.2 mmol/l versus PE 1.2 ± 0.4 mmol/l, p = 0.162) and parathyroid hormone (healthy 26.9 ± 14 pg/ml versus PE 35.3 ± 17.6 pg/ml, p = 0.08) showed no significant differences between the groups. Significantly lower serum calcium (healthy 2.3 ± 0.1 mmol/l versus PE 2.2 ± 0.2 mmol/l, p < 0.005) and serum 25-Hydroxyvitamin D (healthy 39.3 ± 16.7 nmol/l versus PE 23.9 ± 16.9 nmol/l, p < 0.005) were observed in preeclamptic women. Conclusion: Pregnancies complicated by PE show no signs of high bone turnover and may not lead to a higher risk of osteoporosis in later life.


Scientific Reports | 2017

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes

L Küssel; Harald Herkner; Markus Wahrmann; Farsad Eskandary; Konstantin Doberer; Julia Binder; Petra Pateisky; Harald Zeisler; Georg A. Böhmig; Gregor Bond

The significance of antibodies directed against paternal epitopes in the context of obstetric disorders is discussed controversially. In this study anti-HLA and anti-MIC-A antibodies were analysed in sera of women with uneventful pregnancy (n = 101), preeclampsia (PE, n = 55) and gestational diabetes (GDM, n = 36) using antigen specific microbeads. While two thirds of the women with uneventful pregnancy or GDM were HLA and MIC-A antibody positive in gestational week 11 to 13 with a modest increase towards the end of pregnancy, women with PE showed an inverse kinetic: 90% were HLA antibody positive in gestational week 11 to 13 and only 10% showed HLA reactivities at the end of the pregnancy. HLA antibody binding strength was more pronounced in gestational week 14 to 17 in patients with PE compared to women with uneventful pregnancy (maximum median fluorescence intensity of the highest ranked positive bead 7403, IQR 2193–7938 vs. 1093, IQR 395–5689; p = 0.04) and was able to predict PE with an AUC of 0.80 (95% CI 0.67–0.93; p = 0.002). Our data suggest a pathophysiological involvement of HLA antibodies in PE. HLA antibody quantification in early pregnancy may provide a useful tool to increase diagnostic awareness in women prone to develop PE.


Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2012

OS051. Web-based scientific data management and standardized specimencollection-important tools for research and scientific exchange.

Julia Wild; L Küssel; Harald Zeisler

INTRODUCTION Data management and specimen collection in scientific research underlie a number of challenges and often have to fit into daily routine as well as meet scientific standards. In the daily routine of E-science, data security combined with maximum user friendliness and autonomy have a clear positive impact on scientific efficiency.Using standardized specimen collection enables for exchanging material between research partners and helps answering scientific questions in shorter time period and with more scientific outcome. OBJECTIVES We aim to establish SOPs for specimen collection and data management in obstetrics to ensure high quality and comparability in research. METHODS We present a web-based scientific platform for obstetrical data management and show SOPs for high quality specimen collection. RESULTS The database was designed to administrate data concerning pregnancy, child-bed and the newborn and is by now fully integrated in clinical and scientific routine. It consists of documentation sheets that guarantee high quality data management and help administrating data protected by username and password. For answering scientific questions not only good data management but also SOPs for specimen collection are an important tool. Therefore we assessed protocols for standardized blood, urine and placenta collection which make material sampled on different study sites comparable. CONCLUSION Standardized data and specimen collection are necessary for research co-operations and play an important role in answering scientific questions in a shorter time period and with enlarging sample size.


Geburtshilfe Und Frauenheilkunde | 2011

Vitamin D Defizienz als Risikofaktor der Präeklampsieentstehung? -eine retrospektive Studie

J Wild; L Küssel; Harald Zeisler

Helical tomotherapy affords to irradiate very large and irregular shaped target volumes with optimal protection of the surrounding normal tissue. This innovative technique facilitates treating patients with inoperable and chemotherapeutically uncontrollable local recurrence of breast cancer with good palliative results and low to moderate acute toxicity. Additionally it is possible to continue chemotherapy in order to control progressive systemic disease without increasing acute toxicity.


Geburtshilfe Und Frauenheilkunde | 2015

Preeclampsia – a risk factor for osteoporosis? – Analysis of maternal sclerostin levels and markers of bone turnover in patients with preeclampsia

J Wild; P Pateisky; L Küssel; W Huf; J Ott; P Haslinger; Martin Knöfler; Harald Zeisler


Geburtshilfe Und Frauenheilkunde | 2013

Schwere Pfropf-Präeklampsie in der 23. Schwangerschaftswoche – Schwangerschaftsabbruch indiziert? – Ein Fallbericht

J Wild; P Pateisky; L Küssel; Kinga Chalubinski; Harald Zeisler


Geburtshilfe Und Frauenheilkunde | 2013

Eizellspende als Risikofaktor für die Entstehung einer Präeklampsie? – Ein Fallbericht

P Pateisky; J Wild; L Küssel; Kinga Chalubinski; Harald Zeisler


Geburtshilfe Und Frauenheilkunde | 2012

25-Hydroxyvitamin D – Schlüssel der Präeklampsie-Entstehung?

J Wild; L Küssel; P Pateisky; W Huf; Harald Zeisler


Geburtshilfe Und Frauenheilkunde | 2011

Entbindung im Intervall nach eklamptischem Anfall – ein Fallbericht

J Wild; L Küssel; Harald Zeisler

Collaboration


Dive into the L Küssel's collaboration.

Top Co-Authors

Avatar

Harald Zeisler

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Georg A. Böhmig

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Julia Wild

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Markus Wahrmann

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Martin Knöfler

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Petra Pateisky

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Farsad Eskandary

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Gregor Bartel

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Gregor Bond

Medical University of Vienna

View shared research outputs
Researchain Logo
Decentralizing Knowledge